An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

被引:410
作者
Meyer, Keith C. [1 ]
Raghu, Ganesh [2 ]
Verleden, Geert M. [3 ]
Corris, Paul A. [4 ]
Aurora, Paul [5 ]
Wilson, Kevin C. [6 ]
Brozek, Jan [7 ]
Glanville, Allan R. [8 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Univ Leuven, Leuven, Belgium
[4] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[5] Great Ormond St Hosp Sick Children, London WC1N 3JH, England
[6] Boston Univ, Med Ctr, Boston, MA USA
[7] McMaster Univ, Hamilton, ON, Canada
[8] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW 2010, Australia
关键词
LUNG-TRANSPLANT RECIPIENTS; GASTROESOPHAGEAL-REFLUX DISEASE; LAPAROSCOPIC NISSEN FUNDOPLICATION; REGULATORY T-CELLS; CHRONIC ALLOGRAFT-REJECTION; THIN-SECTION CT; TOTAL LYMPHOID IRRADIATION; PRIMARY GRAFT DYSFUNCTION; MINIMAL ACUTE REJECTION; LONG-TERM AZITHROMYCIN;
D O I
10.1183/09031936.00107514
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Bronchiolitis obliterans syndrome (BUS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describe and/or provide recommendations for 1) the definition of BUS, 2) the risk factors for developing BUS, 3) the diagnosis of BUS, and 4) the management and prevention of BUS. A pragmatic evidence synthesis was performed to identify all unique citations related to BUS published from 1980 through to March, 2013. The expert committee discussed the available research evidence upon which the updated definition of BUS, identified risk factors and recommendations are based. The committee followed the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach to develop specific clinical recommendations. The term BOS should be used to describe a delayed allograft dysfunction with persistent decline in forced expiratory volume in 1 s that is not caused by other known and potentially reversible causes of post-transplant loss of lung function. The committee formulated specific recommendations about the use of systemic corticosteroids, cyclosporine, tacrolimus, azithromycin and about re-transplantation in patients with suspected and confirmed BUS. The diagnosis of BUS requires the careful exclusion of other post-transplant complications that can cause delayed lung allograft dysfunction, and several risk factors have been identified that have a significant association with the onset of BUS. Currently available therapies have not been proven to result in significant benefit in the prevention or treatment of BUS. Adequately designed and executed randomised controlled trials that properly measure and report all patient-important outcomes are needed to identify optimal therapies for established BUS and effective strategies for its prevention.
引用
收藏
页码:1479 / 1503
页数:25
相关论文
共 180 条
[1]   The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease [J].
Afzali, B. ;
Lombardi, G. ;
Lechler, R. I. ;
Lord, G. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (01) :32-46
[2]   Clinical Ex Vivo Lung Perfusion - Pushing the Limits [J].
Aigner, C. ;
Slama, A. ;
Hoetzenecker, K. ;
Scheed, A. ;
Urbanek, B. ;
Schmid, W. ;
Nierscher, F. J. ;
Lang, G. ;
Klepetko, W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) :1839-1847
[3]   Pulmonary retransplantation: Is it worth the effort? A long-term analysis of 46 cases [J].
Aigner, Clemens ;
Jaksch, Peter ;
Taghavi, Shahrokh ;
Lang, Gyoergy ;
Reza-Hoda, Mir Ali ;
Wisser, Wilfried ;
Klepetko, Walter .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (01) :60-65
[4]   Azithromycin for Prevention of Exacerbations of COPD [J].
Albert, Richard K. ;
Connett, John ;
Bailey, William C. ;
Casaburi, Richard ;
Cooper, J. Allen D., Jr. ;
Criner, Gerard J. ;
Curtis, Jeffrey L. ;
Dransfield, Mark T. ;
Han, MeiLan K. ;
Lazarus, Stephen C. ;
Make, Barry ;
Marchetti, Nathaniel ;
Martinez, Fernando J. ;
Madinger, Nancy E. ;
McEvoy, Charlene ;
Niewoehner, Dennis E. ;
Porsasz, Janos ;
Price, Connie S. ;
Reilly, John ;
Scanlon, Paul D. ;
Sciurba, Frank C. ;
Scharf, Steven M. ;
Washko, George R. ;
Woodruff, Prescott G. ;
Anthonisen, Nicholas R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :689-698
[5]  
[Anonymous], FDA DRUG SAF COMM AZ
[6]   OBLITERATIVE BRONCHIOLITIS AFTER LUNG AND HEART-LUNG TRANSPLANTATION - AN ANALYSIS OF RISK-FACTORS AND MANAGEMENT [J].
BANDO, K ;
PARADIS, IL ;
SIMILO, S ;
KONISHI, H ;
KOMATSU, K ;
ZULLO, TG ;
YOUSEM, SA ;
CLOSE, JM ;
ZEEVI, A ;
DUQUESNOY, RJ ;
MANZETTI, J ;
KEENAN, RJ ;
ARMITAGE, JM ;
HARDESTY, RL ;
GRIFFITH, BP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :4-14
[7]   Bronchiolitis obliterans syndrome in heart-lung transplant recipients: Diagnosis with expiratory CT [J].
Bankier, AA ;
Van Muylem, A ;
Knoop, C ;
Estenne, M ;
Gevenois, PA .
RADIOLOGY, 2001, 218 (02) :533-539
[8]  
Belperio John A, 2009, Proc Am Thorac Soc, V6, P108, DOI 10.1513/pats.200807-073GO
[9]   High prevalence of gastroesophageal reflux in children after lung transplantation [J].
Benden, C ;
Aurora, P ;
Curry, J ;
Whitmore, P ;
Priestley, L ;
Elliott, MJ .
PEDIATRIC PULMONOLOGY, 2005, 40 (01) :68-71
[10]   Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience [J].
Benden, Christian ;
Speich, Rudolf ;
Hofbauer, Guenther E. ;
Irani, Sarosh ;
Eich-Wanger, Christine ;
Russi, Erich W. ;
Weder, Walter ;
Boehler, Annette .
TRANSPLANTATION, 2008, 86 (11) :1625-1627